SCHEMBL2565302

SCHEMBL2565302

CN(CCCOCCCCCCN)Cc1c(Cl)cccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.40
KDM4E B2RXH2 4/20 0.38
TAAR1 Q96RJ0 2/20 0.38
POLB P06746 1/20 0.38
CARM1 Q86X55 2/20 0.37
PRMT6 Q96LA8 2/20 0.37
PRMT8 Q9NR22 2/20 0.37
PRMT3 O60678 1/20 0.37
CHRM2 P08172 2/20 0.37
PRMT1 Q99873 1/20 0.36
MAPK1 P28482 3/20 0.34
MAPT P10636 2/20 0.34
ATM Q13315 1/20 0.34
MAOA P21397 2/20 0.33
MAOB P27338 2/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2565598 0.94 TAAR1 (0.38) HPGDKDM4ETAAR1POLBCARM1
SCHEMBL2570711 0.77 ACHE (0.57) MAOB
SCHEMBL15614684 0.76 ADRB2 (0.45) KDM4ETAAR1POLBMAPK1MAPT
SCHEMBL2563909 0.72 ACHE (0.54) MAOB
SCHEMBL13909718 0.71 CARM1 (0.62) CARM1PRMT6PRMT8TSHRLMNA
SCHEMBL2565307 0.70 TAAR1 (0.39) KDM4ETAAR1POLBMAPK1MAPT
SCHEMBL2565305 0.70 KDM4E (0.51) KDM4ETAAR1POLBCHRM2MAPK1
SCHEMBL8743692 0.69 LMNA (0.59) KDM4ECARM1PRMT6PRMT8MAPK1
Hydrochloric Acid SCHEMBL8743634 0.68 LMNA (0.57) KDM4ECARM1PRMT6PRMT8PRMT1
SCHEMBL15614733 0.67 ADRB2 (0.49) HPGDKDM4ETAAR1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013183-B1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR ALMIRALL SA (ES) 2011-11-02 EP disclosed
US-20090082378-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE B2 ADRENERGIC RECEPTOR LABORATORIOS ALMIRALL, S.A. (ES) 2009-03-26 US disclosed
EP-2013183-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR Laboratorios Almirall, S.A. (ES) 2009-01-14 EP disclosed
WO-2007124898-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR LABORATORIOS, ALMIRALL S.A. (ES) 2007-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082378-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE B2 ADRENERGIC RECEPTOR ADRB2, ADRA2C, ADRB1 HPGD 244/4885KDM4E 3289/4885TAAR1 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.